What does this research mean for the field?

Warfarin remains a valuable therapeutic option, and a stratified approach to selecting oral anticoagulants and their dosages improves patient outcomes and affordability compared to a complete switchover to direct oral anticoagulants (DOACs). Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

June 28, 2018Journal of Personalized MedicineOpen Access

Warfarin: The End or the End of One Size Fits All Therapy?

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

Munir PirmohamedAstraZeneca (United Kingdom)

Discussion

Member takes

Implication

Stratified warfarin use may optimize outcomes and affordability in select patients; leaves open the need for prospective validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Munir Pirmohamed (2018) studied this question.

synapsesocial.com/papers/6a19973eed753a62dff64319 https://doi.org/10.3390/jpm8030022

Topics

Atrial fibrillation Anticoagulation in AF Persistent AF management

View Full Paper

Ask AI

Bookmark

Warfarin: The End or the End of One Size Fits All Therapy?

Discussion

Member takes

Implication

Key Points

Cite This Study

Topics

Warfarin: The End or the End of One Size Fits All Therapy?

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Topics

Also Consider